Dhanuka Agritech Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Dhanuka Agritech verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 8.2%, während die Gewinne der Branche Chemicals jährlich um gewachsen und zwar um 6.4%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 8.7%. Die Eigenkapitalrendite von Dhanuka Agritech beträgt 17.1% und die Nettomargen betragen 14.2%.
Wichtige Informationen
8.23%
Wachstumsrate der Gewinne
9.16%
EPS-Wachstumsrate
| Chemicals Wachstum der Industrie | 17.68% |
| Wachstumsrate der Einnahmen | 8.72% |
| Eigenkapitalrendite | 17.08% |
| Netto-Marge | 14.22% |
| Letzte Ertragsaktualisierung | 31 Mar 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Narrativ-Update • May 03
507717: Upcoming Director Appointment Will Support Future Upside Confidence
Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).Narrativ-Update • Apr 18
507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence
Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).Narrativ-Update • Apr 03
507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence
Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).Narrativ-Update • Mar 19
507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential
Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).Narrativ-Update • Mar 05
507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential
Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
Neues Narrativ • Feb 21
Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?Narrativ-Update • Feb 19
507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential
Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Neues Narrativ • Feb 06
Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?Narrativ-Update • Feb 04
507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.Narrativ-Update • Jan 21
507717: Higher Margin Outlook Will Support Long-Term Upside Potential
Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.Narrativ-Update • Jan 06
507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).Narrativ-Update • Dec 16
507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential
Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.Narrativ-Update • Dec 02
507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum
Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).Narrativ-Update • Nov 17
507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion
Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.Narrativ-Update • Nov 03
507717: New Nagpur Plant And Higher Margins Will Drive Future Upside
Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.Narrativ-Update • Sep 05
Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand
With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
Neues Narrativ • Feb 09
Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets
International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Dhanuka Agritech Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 20,198 | 2,872 | 1,898 | 0 |
| 31 Dec 25 | 19,785 | 2,650 | 1,993 | 0 |
| 30 Sep 25 | 20,138 | 2,800 | 1,967 | 0 |
| 30 Jun 25 | 20,699 | 3,036 | 1,955 | 0 |
| 31 Mar 25 | 20,352 | 2,970 | 1,917 | 0 |
| 31 Dec 24 | 19,614 | 2,805 | 1,881 | 0 |
| 30 Sep 24 | 19,194 | 2,708 | 1,858 | 0 |
| 30 Jun 24 | 18,831 | 2,550 | 1,832 | 0 |
| 31 Mar 24 | 17,585 | 2,391 | 1,745 | 0 |
| 31 Dec 23 | 17,615 | 2,454 | 1,612 | 0 |
| 30 Sep 23 | 17,516 | 2,461 | 1,522 | 0 |
| 30 Jun 23 | 16,766 | 2,173 | 1,426 | 0 |
| 31 Mar 23 | 17,002 | 2,335 | 1,442 | 0 |
| 31 Dec 22 | 16,473 | 2,226 | 1,399 | 0 |
| 30 Sep 22 | 16,108 | 2,191 | 1,387 | 0 |
| 30 Jun 22 | 15,067 | 2,094 | 1,380 | 0 |
| 31 Mar 22 | 14,778 | 2,089 | 1,352 | 0 |
| 31 Dec 21 | 14,350 | 2,031 | 1,324 | 0 |
| 30 Sep 21 | 13,738 | 2,007 | 1,293 | 0 |
| 30 Jun 21 | 13,774 | 2,074 | 1,293 | 0 |
| 31 Mar 21 | 13,875 | 2,106 | 1,314 | 0 |
| 31 Dec 20 | 13,395 | 2,009 | 1,237 | 0 |
| 30 Sep 20 | 13,153 | 1,886 | 1,234 | 0 |
| 30 Jun 20 | 12,749 | 1,785 | 1,131 | 0 |
| 31 Mar 20 | 11,201 | 1,413 | 1,128 | 0 |
| 31 Dec 19 | 10,852 | 1,291 | 1,185 | 0 |
| 30 Sep 19 | 10,305 | 1,160 | 1,156 | 0 |
| 30 Jun 19 | 10,118 | 1,111 | 1,163 | 0 |
| 31 Mar 19 | 10,058 | 1,126 | 1,174 | 0 |
| 31 Dec 18 | 9,982 | 1,145 | 1,255 | 0 |
| 30 Sep 18 | 10,029 | 1,285 | 1,294 | 0 |
| 30 Jun 18 | 9,676 | 1,262 | 1,253 | 0 |
| 31 Mar 18 | 9,626 | 1,262 | 1,246 | 0 |
| 31 Dec 17 | 9,265 | 1,201 | 1,189 | 0 |
| 30 Sep 17 | 9,168 | 1,183 | 1,156 | 0 |
| 30 Jun 17 | 8,812 | 1,156 | 1,132 | 0 |
| 31 Mar 17 | 8,833 | 1,219 | 1,118 | 0 |
| 31 Dec 16 | 8,886 | 1,237 | 1,152 | 0 |
| 30 Sep 16 | 8,857 | 1,196 | 1,102 | 0 |
| 30 Jun 16 | 8,469 | 1,081 | 1,061 | 0 |
| 31 Mar 16 | 8,289 | 1,073 | 1,003 | 0 |
| 31 Dec 15 | 8,116 | 1,007 | 1,483 | 10 |
| 30 Sep 15 | 7,850 | 1,002 | 684 | 0 |
| 30 Jun 15 | 7,977 | 1,042 | 662 | 0 |
Qualität der Erträge: 507717 hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: 507717Die aktuellen Gewinnspannen (14.2%) sind niedriger als im letzten Jahr (14.6%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 507717In den letzten 5 Jahren sind die Gewinne von 8.2% jährlich gestiegen.
Beschleunigtes Wachstum: 507717Das Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.
Erträge im Vergleich zur Industrie: 507717 hatte im vergangenen Jahr ein negatives Gewinnwachstum (-3.3%), was einen Vergleich mit dem Branchendurchschnitt Chemicals (10.3%) erschwert.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 507717Die Eigenkapitalrendite des Unternehmens (17.1%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/27 00:36 |
| Aktienkurs zum Tagesende | 2026/05/27 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2026/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Dhanuka Agritech Limited wird von 17 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |